March 05, 2015 1:36 AM ET

Healthcare Equipment and Supplies

Company Overview of West Pharmaceutical Services, Inc.

Company Overview

West Pharmaceutical Services, Inc. develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The Pharmaceutical Packaging Systems segment offers packaging components and systems for injectable drug delivery, such as stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. This segment also provides contract analytical laboratory...

530 Herman O. West Drive

Exton, PA 19341

United States

Founded in 1923

7,000 Employees

Phone:

610-594-2900

Key Executives for West Pharmaceutical Services, Inc.

Chairman and Chief Executive Officer
Age: 56
Total Annual Compensation: $825.0K
Chief Financial Officer and Senior Vice President
Age: 54
Total Annual Compensation: $457.9K
President of Pharmaceutical Packaging Systems Asia-Pacific Region
Age: 54
Total Annual Compensation: $359.3K
President of Pharmaceutical Delivery Systems
Age: 57
Total Annual Compensation: $339.9K
Compensation as of Fiscal Year 2013.

West Pharmaceutical Services, Inc. Key Developments

West Pharmaceutical Services, Inc. Announces Dividend for the Second Quarter of 2015, Payable on May 6, 2015

West Pharmaceutical Services, Inc. announced that the company's Board of Directors has approved a second-quarter 2015 dividend of $0.11 per share. The dividend will be paid on May 6, 2015 to shareholders of record as of April 22, 2015.

West Pharmaceutical Services, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter and Full Year of 2015

West Pharmaceutical Services, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $349.8 million against $342.7 million a year ago. Operating profit was $44.6 million against $36.9 million a year ago. Income before income taxes was $41.7 million against $33.5 million a year ago. Net income was $31.4 million or $0.43 assuming diluted per share against $23.6 million or $0.33 assuming diluted per share a year ago. Non-GAAP operating profit was $44.6 million against $36.9 million a year ago. Adjusted net income improved 22.5% to $33.2 million, compared to $27.1 million in the 2013 quarter, and adjusted diluted EPS increased to $0.45 in the quarter, compared to $0.38 in the prior-year period. For the year, the company reported net sales of $1,421.4 million against $1,368.4 million a year ago. Operating profit was $182.0 million against $162.4 million a year ago. Income before income taxes was $169.0 million against $147.1 million a year ago. Net income was $127.1 million or $1.75 assuming diluted per share against $112.3 million or $1.57 assuming diluted per share a year ago. Non-GAAP operating profit was $183.2 million against $162.4 million a year ago. Non-GAAP net income was $162.4 million against $116.1 million a year ago. Operating cash flow was $182.9 million against $220.5 million a year ago. Capital expenditures was $111.9 million against $151.9 million a year ago. The company expected full-year 2015 consolidated net sales between $1,430 million to $1,460 million, full-year adjusted diluted EPS between $1.74 to $1.92. The Company estimates its 2015 capital spending at between $150 million and $175 million, including approximately $35 million related to the planned new facility in Waterford, Ireland. Capital spending in 2014 was $111.9 million. The company expects first quarter 2015 revenues to grow 5% to 7%, excluding currency effects, over the first quarter 2014 and for growth in adjusted diluted EPS to be in the low teens.

West Pharmaceutical Services, Inc. to Report Q4, 2014 Results on Feb 19, 2015

West Pharmaceutical Services, Inc. announced that they will report Q4, 2014 results at 9:00 AM, US Eastern Standard Time on Feb 19, 2015

Similar Private Companies By Industry

Company Name Region
Leesar Healthtrust Partners LC United States
Hanger Prosthetics & Orthotics West, Inc. United States
Applied Harmonics Corporation United States
Shelhigh, Inc. United States
Hu-Friedy Mfg. Co., LLC United States

Recent Private Companies Transactions

Type
Date
Target
Buyback
October 30, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact West Pharmaceutical Services, Inc., please visit www.westpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.